Macquarie Group’s Genesis Healthcare, Inc. GEN Stock Holding History

Macquarie Group’s Portfolio GEN Stock Details GEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-70,820	Closed	-$84K	–	2208
2018 Q4	$84K	Sell	70,820 -147,147	-68%	-$218K	﹤0.01%	1525
2018 Q3	$294K	Sell	217,967 -97,000	-31%	-$154K	﹤0.01%	1410
2018 Q2	$721K	Buy	314,967 +67,300	+27%	+$130K	﹤0.01%	1263
2018 Q1	$374K	Sell	247,667 -186,915	-43%	-$219K	﹤0.01%	1483
2017 Q4	$332K	Sell	434,582 -3,281	-0.7%	-$2.93K	﹤0.01%	1571
2017 Q3	$508K	Buy	+437,863	New	+$552K	﹤0.01%	1443

Other funds holding GEN

VCM

V3 Capital Management Dallas, Texas $33.4M AUM 5.9% 1-Year Est. Return

FWC

First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CPA

Columbia Pacific Advisors Seattle, Washington $31M AUM 29.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

GWS

Glassman Wealth Services Vienna, Virginia $736M AUM 17.99% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Macquarie Group's GEN Position: Q1 2019 in Review

Macquarie Group sold out of Genesis Healthcare, Inc. (GEN) in Q1 2019, closing a stake of 70,820 shares — an estimated $84K sold.

Macquarie Group first reported a position in GEN in Q3 2017 and held it in 6 quarters. The position peaked at $721K in Q2 2018. 77 funds tracked by Wall St. Rank hold GEN as of Q1 2019.

Macquarie Group reported no remaining Genesis Healthcare, Inc. position as of Q1 2019 after selling out during the quarter.
Macquarie Group sold 70,820 Genesis Healthcare, Inc. shares in Q1 2019, an estimated $84K.
Macquarie Group first reported a position in Genesis Healthcare, Inc. in Q3 2017 and held it in 6 quarters.
Macquarie Group's Genesis Healthcare, Inc. position peaked at $721K in Q2 2018.
77 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q1 2019.

Based on Macquarie Group's 13F filing for Q1 2019, filed 15 May 2019.